Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo.

[1]  Jinsong Zhang,et al.  Cyclophosphamide suppresses thioredoxin reductase in bladder tissue and its adaptive response via inductions of thioredoxin reductase and glutathione peroxidase. , 2006, Chemico-biological interactions.

[2]  P. Nguyen,et al.  Thioredoxin reductase as a novel molecular target for cancer therapy. , 2006, Cancer letters.

[3]  V. Gladyshev,et al.  Thioredoxin Reductase 1 Deficiency Reverses Tumor Phenotype and Tumorigenicity of Lung Carcinoma Cells* , 2006, Journal of Biological Chemistry.

[4]  Elias S. J. Arnér,et al.  Interactions of Nitroaromatic Compounds with the Mammalian Selenoprotein Thioredoxin Reductase and the Relation to Induction of Apoptosis in Human Cancer Cells* , 2006, Journal of Biological Chemistry.

[5]  E. Niki,et al.  4-Hydroxynonenal Induces Adaptive Response and Enhances PC12 Cell Tolerance Primarily through Induction of Thioredoxin Reductase 1 via Activation of Nrf2* , 2005, Journal of Biological Chemistry.

[6]  Elias S. J. Arnér,et al.  Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds. , 2005, Free radical biology & medicine.

[7]  A. Holmgren,et al.  Thioredoxin Reductase Is Irreversibly Modified by Curcumin , 2005, Journal of Biological Chemistry.

[8]  M. Tsujimoto,et al.  Transcriptional regulation of thioredoxin reductase 1 expression by cadmium in vascular endothelial cells: Role of NF‐E2‐related factor‐2 , 2005, Journal of cellular physiology.

[9]  Keiichiro Suzuki,et al.  Induction of thioredoxin reductase as an adaptive response to acrolein in human umbilical vein endothelial cells. , 2005, Biochemical and biophysical research communications.

[10]  D. Beach,et al.  A mutation in a thioredoxin reductase homolog suppresses p53-induced growth inhibition in the fission yeastSchizosaccharomyces pombe , 1996, Molecular and General Genetics MGG.

[11]  S. Rodenhuis,et al.  Clinical Pharmacokinetics of Cyclophosphamide , 1979, Clinical pharmacokinetics.

[12]  Xuli Wu,et al.  Effect of acrolein and glutathione depleting agents on thioredoxin. , 2004, Toxicology.

[13]  D. Bigner,et al.  Repair analysis of 4-hydroperoxycyclophosphamide-induced DNA interstrand crosslinking in the c-myc gene in 4-hydroperoxycyclophosphamide-sensitive and-resistant medulloblastoma cell lines , 1995, Cancer Chemotherapy and Pharmacology.

[14]  S. Biswal,et al.  Modulation of benzo[a]pyrene-induced p53 DNA activity by acrolein. , 2003, Carcinogenesis.

[15]  Elias S. J. Arnér,et al.  Rapid Induction of Cell Death by Selenium-compromised Thioredoxin Reductase 1 but Not by the Fully Active Enzyme Containing Selenocysteine* , 2003, The Journal of Biological Chemistry.

[16]  G. Williamson,et al.  Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation. , 2003, Carcinogenesis.

[17]  Keiichiro Suzuki,et al.  Induction of Thioredoxin Reductase Gene Expression by Peroxynitrite in Human Umbilical Vein Endothelial Cells , 2002, Biological chemistry.

[18]  Elias S. J. Arnér,et al.  Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. , 2001, Free radical biology & medicine.

[19]  D. Waxman,et al.  Cyclophosphamide induces caspase 9-dependent apoptosis in 9L tumor cells. , 2001, Molecular pharmacology.

[20]  D. Scudiero,et al.  P450 enzyme expression patterns in the NCI human tumor cell line panel. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[21]  Elias S. J. Arnér,et al.  Physiological functions of thioredoxin and thioredoxin reductase. , 2000, European journal of biochemistry.

[22]  R. Bonfil,et al.  Mechanism of antimetastatic immunopotentiation by low-dose cyclophosphamide. , 2000, European journal of cancer.

[23]  A. Holmgren,et al.  Possible involvement of thioredoxin reductase as well as thioredoxin in cellular sensitivity to cis-diamminedichloroplatinum (II). , 1999, Free radical biology & medicine.

[24]  Colvin Om.  An overview of cyclophosphamide development and clinical applications. , 1999 .

[25]  M. Dolan,et al.  Modulation of cyclophosphamide activity by O 6-alkylguanine-DNA alkyltransferase , 1999, Cancer Chemotherapy and Pharmacology.

[26]  Kohei Miyazono,et al.  Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1 , 1998, The EMBO journal.

[27]  J. M. May,et al.  Reduction of Dehydroascorbate to Ascorbate by the Selenoenzyme Thioredoxin Reductase* , 1997, The Journal of Biological Chemistry.

[28]  Elias S. J. Arnér,et al.  Efficient reduction of lipoamide and lipoic acid by mammalian thioredoxin reductase. , 1996, Biochemical and biophysical research communications.

[29]  Mats Andersson,et al.  NK-lysin, a Disulfide-containing Effector Peptide of T-lymphocytes, Is Reduced and Inactivated by Human Thioredoxin Reductase , 1996, The Journal of Biological Chemistry.

[30]  A. Holmgren,et al.  [21] Thioredoxin and thioredoxin reductase , 1995 .

[31]  D. Crowther,et al.  Cyclophosphamide decreases O6-alkylguanine-DNA alkyltransferase activity in peripheral lymphocytes of patients undergoing bone marrow transplantation. , 1992, British Journal of Cancer.

[32]  A. Holmgren,et al.  Thioredoxin and glutaredoxin systems. , 2019, The Journal of biological chemistry.

[33]  Y. Sun,et al.  A simple method for clinical assay of superoxide dismutase. , 1988, Clinical chemistry.

[34]  W B Jakoby,et al.  Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. , 1974, The Journal of biological chemistry.

[35]  H. Ganther,et al.  Selenium: Biochemical Role as a Component of Glutathione Peroxidase , 1973, Science.

[36]  G. Ellman,et al.  Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.